Article
The serotonin 1B receptor is required for some of the behavioral effects of psilocybin in mice
2024-10-21
Abstract excerpt
Recent studies highlight the promising use of psychedelic therapies for psychiatric disorders, including depression. The persisting clinical effects of psychedelics such as psilocybin are commonly attributed to activation of the serotonin 2A receptor (5-HT2AR) based on its role in the acute hallucinatory effects. However, the active metabolite of psilocybin binds to many serotonin receptor subtypes, including the...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 5aee15c8-1df4-552a-ad7d-b52ec799816b
- DOI
- 10.1101/2024.10.18.618582
